Which has preferable valuation & earnings, LABT or AIMDW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Lakewood-Amedex Biotherapeutics N/A N/A N/A N/A N/A Ainos $18.11K N/A N/A N/A N/A

Is LABT or AIMDW more profitable?

Company Net Margins Return on Equity Return on Assets Lakewood-Amedex Biotherapeutics N/A N/A N/A Ainos N/A N/A N/A

Which has higher earnings & valuation, ALVOW or LABT?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Alvotech $559.42M N/A N/A N/A N/A Lakewood-Amedex Biotherapeutics N/A N/A N/A N/A N/A

Is ALVOW or LABT more profitable?

Company Net Margins Return on Equity Return on Assets Alvotech N/A N/A N/A Lakewood-Amedex Biotherapeutics N/A N/A N/A

Which has stronger valuation & earnings, LABT or ARAV?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Lakewood-Amedex Biotherapeutics N/A N/A N/A N/A N/A Aravive N/A N/A N/A -$0.90 N/A

Is LABT or ARAV more profitable?

Company Net Margins Return on Equity Return on Assets Lakewood-Amedex Biotherapeutics N/A N/A N/A Aravive N/A N/A N/A

Which has stronger valuation & earnings, LABT or ACABW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Lakewood-Amedex Biotherapeutics N/A N/A N/A N/A N/A Atlantic Coastal Acquisition Corp. II N/A N/A N/A N/A N/A

Is LABT or ACABW more profitable?

Company Net Margins Return on Equity Return on Assets Lakewood-Amedex Biotherapeutics N/A N/A N/A Atlantic Coastal Acquisition Corp. II N/A N/A N/A

Which has stronger earnings and valuation, BFRIW or LABT?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Biofrontera $43.20M N/A N/A N/A N/A Lakewood-Amedex Biotherapeutics N/A N/A N/A N/A N/A

Is BFRIW or LABT more profitable?

Company Net Margins Return on Equity Return on Assets Biofrontera N/A N/A N/A Lakewood-Amedex Biotherapeutics N/A N/A N/A

Lakewood-Amedex Biotherapeutics (LABT) Competitors

$0.73 -0.01 (-0.68%)

Closing price 04:00 PM Eastern

Extended Trading

$0.75 +0.01 (+1.91%)

As of 07:39 PM Eastern

Compare

LABT vs. AIMDW, ALVOW, ARAV, ACABW, and BFRIW

Should you buy Lakewood-Amedex Biotherapeutics stock or one of its competitors? MarketBeat compares Lakewood-Amedex Biotherapeutics with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Lakewood-Amedex Biotherapeutics include Ainos (AIMDW), Alvotech (ALVOW), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), and Biofrontera (BFRIW). These companies are all part of the "pharmaceutical products" industry.

How does Lakewood-Amedex Biotherapeutics compare to Ainos?

Lakewood-Amedex Biotherapeutics (NASDAQ:LABT) and Ainos (NASDAQ:AIMDW) are both pharmaceutical products companies, but which is the better investment? We will contrast the two businesses based on the strength of their media sentiment, valuation, analyst recommendations, profitability, earnings, dividends, risk and institutional ownership.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lakewood-Amedex Biotherapeutics	N/A	N/A	N/A	N/A	N/A
Ainos	$18.11K	N/A	N/A	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
Lakewood-Amedex Biotherapeutics	N/A	N/A	N/A
Ainos	N/A	N/A	N/A

In the previous week, Lakewood-Amedex Biotherapeutics had 1 more articles in the media than Ainos. MarketBeat recorded 1 mentions for Lakewood-Amedex Biotherapeutics and 0 mentions for Ainos. Lakewood-Amedex Biotherapeutics' average media sentiment score of 1.44 beat Ainos' score of 0.93 indicating that Lakewood-Amedex Biotherapeutics is being referred to more favorably in the media.

Company	Overall Sentiment
Lakewood-Amedex Biotherapeutics	Positive
Ainos	Positive

Summary

Lakewood-Amedex Biotherapeutics beats Ainos on 2 of the 3 factors compared between the two stocks.

How does Lakewood-Amedex Biotherapeutics compare to Alvotech?

Alvotech (NASDAQ:ALVOW) and Lakewood-Amedex Biotherapeutics (NASDAQ:LABT) are both pharmaceutical products companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, profitability, dividends, media sentiment, valuation and risk.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alvotech	$559.42M	N/A	N/A	N/A	N/A
Lakewood-Amedex Biotherapeutics	N/A	N/A	N/A	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
Alvotech	N/A	N/A	N/A
Lakewood-Amedex Biotherapeutics	N/A	N/A	N/A

In the previous week, Lakewood-Amedex Biotherapeutics had 1 more articles in the media than Alvotech. MarketBeat recorded 1 mentions for Lakewood-Amedex Biotherapeutics and 0 mentions for Alvotech. Alvotech's average media sentiment score of 1.89 beat Lakewood-Amedex Biotherapeutics' score of 1.44 indicating that Alvotech is being referred to more favorably in the media.

Company	Overall Sentiment
Alvotech	Very Positive
Lakewood-Amedex Biotherapeutics	Positive

Summary

Alvotech beats Lakewood-Amedex Biotherapeutics on 2 of the 3 factors compared between the two stocks.

How does Lakewood-Amedex Biotherapeutics compare to Aravive?

Lakewood-Amedex Biotherapeutics (NASDAQ:LABT) and Aravive (NASDAQ:ARAV) are both pharmaceutical products companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, valuation, profitability, media sentiment and institutional ownership.

Company	Net Margins	Return on Equity	Return on Assets
Lakewood-Amedex Biotherapeutics	N/A	N/A	N/A
Aravive	N/A	N/A	N/A

In the previous week, Lakewood-Amedex Biotherapeutics had 1 more articles in the media than Aravive. MarketBeat recorded 1 mentions for Lakewood-Amedex Biotherapeutics and 0 mentions for Aravive. Lakewood-Amedex Biotherapeutics' average media sentiment score of 1.44 beat Aravive's score of 0.00 indicating that Lakewood-Amedex Biotherapeutics is being referred to more favorably in the media.

Company	Overall Sentiment
Lakewood-Amedex Biotherapeutics	Positive
Aravive	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lakewood-Amedex Biotherapeutics	N/A	N/A	N/A	N/A	N/A
Aravive	N/A	N/A	N/A	-$0.90	N/A

35.8% of Aravive shares are owned by institutional investors. 60.4% of Aravive shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Lakewood-Amedex Biotherapeutics and Aravive tied by winning 2 of the 4 factors compared between the two stocks.

How does Lakewood-Amedex Biotherapeutics compare to Atlantic Coastal Acquisition Corp. II?

Lakewood-Amedex Biotherapeutics (NASDAQ:LABT) and Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) are both pharmaceutical products companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, valuation, profitability, media sentiment and institutional ownership.

Company	Net Margins	Return on Equity	Return on Assets
Lakewood-Amedex Biotherapeutics	N/A	N/A	N/A
Atlantic Coastal Acquisition Corp. II	N/A	N/A	N/A

In the previous week, Lakewood-Amedex Biotherapeutics had 1 more articles in the media than Atlantic Coastal Acquisition Corp. II. MarketBeat recorded 1 mentions for Lakewood-Amedex Biotherapeutics and 0 mentions for Atlantic Coastal Acquisition Corp. II. Lakewood-Amedex Biotherapeutics' average media sentiment score of 1.44 beat Atlantic Coastal Acquisition Corp. II's score of 0.00 indicating that Lakewood-Amedex Biotherapeutics is being referred to more favorably in the media.

Company	Overall Sentiment
Lakewood-Amedex Biotherapeutics	Positive
Atlantic Coastal Acquisition Corp. II	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lakewood-Amedex Biotherapeutics	N/A	N/A	N/A	N/A	N/A
Atlantic Coastal Acquisition Corp. II	N/A	N/A	N/A	N/A	N/A

Summary

Lakewood-Amedex Biotherapeutics beats Atlantic Coastal Acquisition Corp. II on 2 of the 2 factors compared between the two stocks.

How does Lakewood-Amedex Biotherapeutics compare to Biofrontera?

Biofrontera (NASDAQ:BFRIW) and Lakewood-Amedex Biotherapeutics (NASDAQ:LABT) are both pharmaceutical products companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, media sentiment, valuation, risk, profitability, analyst recommendations, earnings and institutional ownership.

Company	Net Margins	Return on Equity	Return on Assets
Biofrontera	N/A	N/A	N/A
Lakewood-Amedex Biotherapeutics	N/A	N/A	N/A

In the previous week, Lakewood-Amedex Biotherapeutics had 1 more articles in the media than Biofrontera. MarketBeat recorded 1 mentions for Lakewood-Amedex Biotherapeutics and 0 mentions for Biofrontera. Biofrontera's average media sentiment score of 1.87 beat Lakewood-Amedex Biotherapeutics' score of 1.44 indicating that Biofrontera is being referred to more favorably in the media.

Company	Overall Sentiment
Biofrontera	Very Positive
Lakewood-Amedex Biotherapeutics	Positive

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biofrontera	$43.20M	N/A	N/A	N/A	N/A
Lakewood-Amedex Biotherapeutics	N/A	N/A	N/A	N/A	N/A

Summary

Biofrontera beats Lakewood-Amedex Biotherapeutics on 2 of the 3 factors compared between the two stocks.

Get Lakewood-Amedex Biotherapeutics News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LABT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

LABT vs. The Competition

Export

Metric	Lakewood-Amedex Biotherapeutics	Pharmaceutical Preparations Industry	Manufacturing Sector	NASDAQ Exchange
Market Cap	$5.14M	$931.03M	$4.33B	$12.35B
Dividend Yield	N/A	4.84%	10.24%	5.67%
P/E Ratio	N/A	1.43	22.22	24.25
Price / Sales	N/A	125.66	170.42	108.09
Price / Cash	N/A	20.06	41.71	56.68
Price / Book	N/A	7.92	25.09	6.69
Net Income	N/A	-$4.88M	$116.61M	$337.12M
7 Day Performance	7.91%	2.09%	1.20%	1.78%
1 Month Performance	-51.07%	1.63%	0.89%	3.64%
1 Year Performance	N/A	45.53%	14.18%	28.19%

Lakewood-Amedex Biotherapeutics Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
LABT Lakewood-Amedex Biotherapeutics	N/A	$0.73 -0.7%	N/A	N/A	$5.14M	N/A	N/A	5	News Coverage Positive News Gap Down
AIMDW Ainos	N/A	$0.12 -2.0%	N/A	+44.9%	$0.00	$18.11K	N/A	40	Gap Down
ALVOW Alvotech	N/A	$0.18 -13.0%	N/A	-80.1%	$0.00	$586.32M	N/A	4	Positive News Gap Up
ARAV Aravive	N/A	$0.04 flat	N/A	N/A	$0.00	N/A	N/A	20	High Trading Volume
ACABW Atlantic Coastal Acquisition Corp. II	N/A	$0.00 flat	N/A	-87.6%	$0.00	N/A	N/A	15

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:LABT) was last updated on 6/16/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Lakewood-Amedex Biotherapeutics (LABT) Competitors

LABT vs. AIMDW, ALVOW, ARAV, ACABW, and BFRIW

How does Lakewood-Amedex Biotherapeutics compare to Ainos?

Summary

How does Lakewood-Amedex Biotherapeutics compare to Alvotech?

Summary

How does Lakewood-Amedex Biotherapeutics compare to Aravive?

Summary

How does Lakewood-Amedex Biotherapeutics compare to Atlantic Coastal Acquisition Corp. II?

Summary

How does Lakewood-Amedex Biotherapeutics compare to Biofrontera?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

LABT vs. The Competition

Lakewood-Amedex Biotherapeutics Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Lakewood-Amedex Biotherapeutics (LABT) Competitors

LABT vs. AIMDW, ALVOW, ARAV, ACABW, and BFRIW

How does Lakewood-Amedex Biotherapeutics compare to Ainos?

Which has preferable valuation & earnings, LABT or AIMDW?

Is LABT or AIMDW more profitable?

Does the media prefer LABT or AIMDW?

Summary

How does Lakewood-Amedex Biotherapeutics compare to Alvotech?

Which has higher earnings & valuation, ALVOW or LABT?

Is ALVOW or LABT more profitable?

Does the media refer more to ALVOW or LABT?

Summary

How does Lakewood-Amedex Biotherapeutics compare to Aravive?

Is LABT or ARAV more profitable?

Does the media favor LABT or ARAV?

Which has stronger valuation & earnings, LABT or ARAV?

Do institutionals and insiders hold more shares of LABT or ARAV?

Summary

How does Lakewood-Amedex Biotherapeutics compare to Atlantic Coastal Acquisition Corp. II?

Is LABT or ACABW more profitable?

Does the media refer more to LABT or ACABW?

Which has stronger valuation & earnings, LABT or ACABW?

Summary

How does Lakewood-Amedex Biotherapeutics compare to Biofrontera?

Is BFRIW or LABT more profitable?

Does the media refer more to BFRIW or LABT?

Which has stronger earnings and valuation, BFRIW or LABT?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

LABT vs. The Competition

Lakewood-Amedex Biotherapeutics Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools